# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Idiopathic pulmonary fibrosis

Familial pulmonary fibrosis
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 71-80 of 364 results.
A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)
Status: Completed
Last Changed: Oct 08, 2020
First Received: Aug 18, 2016
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Valganciclovir, Placebo
Locations: Vanderbilt University Medical Center, Nashville, Tennessee, United States
Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
Status: Completed
Last Changed: Jun 14, 2017
First Received: Oct 04, 2010
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): inhaled carbon monoxide, Oxygen
Locations: University of California San Francisco, San Francisco, California, United States
University of Illinois Chicago, Chicago, Illinois, United States
University of Chicago, Chicago, Illinois, United States
Tulane University, New Orleans, Louisiana, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
... and 4 other locations.
Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).
Status: Completed
Last Changed: Jan 10, 2020
First Received: Jul 06, 2017
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): Pirfenidone
Locations: Regional State Budgetary Institution of Healthcare "Regional Cinilcal Hospital"; Pulmonology, Barnaul, Altaj, Russian Federation
GBUZ Regional clinical hospital #4, Chelyabinsk, Evenkija, Russian Federation
SBEI HPE "The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova"of MoH of RF, Sankt-peterburg, Leningrad, Russian Federation
Central NII tuberkuleza RAMN, Moscow, Moskovskaja Oblast, Russian Federation
Pulmonologii NII FMBA of Russia, Moscow, Moskovskaja Oblast, Russian Federation
... and 7 other locations.
Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis
Status: Recruiting
Last Changed: Oct 22, 2020
First Received: Feb 08, 2017
Disease(s): Idiopathic Pulmonary Fibrosis
Locations: Sterling Hospital, Ahmedabad, India
St. Johns medical College and Hospital, Bangalore, India
Gleneagles Global Hospital, Chennai, India
Sri Ramakrishna Hospital, Coimbatore, India
Artemis Health Institute, Gurgaon, India
... and 11 other locations.
Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis
Status: Completed
Last Changed: Apr 02, 2019
First Received: Apr 07, 2017
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): patientMpower platform, usual care
Locations: Dept. of Respiratory Medicine, Galway, Ireland
68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis
Status: Unknown status
Last Changed: Apr 07, 2017
First Received: Jun 30, 2015
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): 68Ga-BMV101
Locations: Peking Union Medical College Hospital, Beijing, China
Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain
Status: Completed
Last Changed: Aug 01, 2019
First Received: Sep 13, 2017
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): L - Antineoplastic and immunomodulating agents, L01 - Antineoplastic agents, L01X - Other antineoplastic agents, L01XE - Protein kinase inhibitors, L01XE31 - Nintedanib
Locations: Dynamic solutions, Barcelona, Spain
A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Idiopathic Pulmonary Fibrosis
Status: Active, not recruiting
Last Changed: Dec 23, 2019
First Received: Feb 23, 2016
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): KD025, Standard of Care
Locations: Pulmonary Associates, PA, Phoenix, Arizona, United States
University of Arizona, Tucson, Arizona, United States
UC Davis Medical Center, Division of Pulmonary/CC/SM, Sacramento, California, United States
St. Francis Medical Institute, Clearwater, Florida, United States
Pulmonary Disease Specialists, PA, d/b/a PDS Research, Kissimmee, Florida, United States
... and 6 other locations.
Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis
Status: Completed
Last Changed: Oct 27, 2015
First Received: May 15, 2015
Disease(s): Idiopathic Pulmonary Fibrosis
Intervention(s): 4MGS
Locations: Royal Brompton and Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom
Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up
Status: Active, not recruiting
Last Changed: Apr 16, 2019
First Received: Jun 30, 2016
Disease(s): Idiopathic Pulmonary Fibrosis
Locations: Aarhus University Hosptial, Aarhus C, Denmark
Gentofte Hospital, Hellerup, Denmark
Odense University Hospital, Odense, Denmark